Contact us: +49 (0)251 590 657 67
During the Clinical Evaluation process, we collect, assess, and analyze the clinical data of your medical device in order to confirm its safety, performance, and clinical benefit.
The requirements regarding performance and clinical benefit requirements of a medical device may change at any time. We are able to support in the State-of-the-Art analysis to ensure that your product meets the high expectations of the clinical community.
Providing a Safety and Clinical Performance Report (SSCP) has been mandatory for manufacturers since the Medical Device Regulation (MDR) was introduced in 2017. We will support you in meeting the increased level of requirement.
We actively monitor the market and develop appropriate Post-Market Surveillance strategies for your medical device. As a result, we can identify possible complications and trends early and improve the overall safety of medical devices, which are already on the market.
Based on the results of the CER, we help you plan your PMCF activities according to MDCG 2020-7. We support your data collection activities and help with evaluating the results for your PMCF Evaluation Report with a special focus on safety and performance.
A carefully-conducted risk analysis can already significantly improve a medical device's safety, as early as the development phase. Consequently, potential risks associated with the device can be recorded and minimized by taking appropriate measures.
As manufacturer you are required to ensure the biocompatibility of your product. Biological risks, e.g. materials that cause allergic reactions, must be minimized. We can help you meet the requirements according to the ISO 10993 standard.
A sustainably structured and certified quality management system in accordance with ISO 13485 not only helps to control and improve your company, but also to secure it's existence in the long term.
The evaluation process includes clinical performance, analytical performance and scientific validity. This ensures that your medical device meets safety requirements and achieves the intended clinical benefit and complies with the requirements of the IVDR.
PRO-LIANCE has prepared a complete clinical and a complete biological evaluation for a product group. These were completed exactly within the promised time. In the course of the completion, the two experts were very professional, helpful and accommodating. The produced documents make an excellent impression.
Martin von Rüden, Regulatory Affairs Manager at QUESTALPHA GmbH
I find the level of advice and feedback on the clinical evaluation process to be very valuable, this is where real collaboration takes place.
Sr. Director Clinical Affairs,World market leader in the field of industrial endoscopy
With the quality management advice from PRO-LIANCEwe are completely satisfied!!
QM manager, manufacturer of medical products for dermatology,plastic surgery and aesthetic medicine
In the course of Regulatory Affairs Consulting we always had a permanent contact person.
Managing director, manufacturer of medical textilesfor chronic inflammatory skin diseases
PRO-LIANCE staff is very professional, they deliver high quality documents within agreed timelines, they are very responsive and flexible to changes sometimes on a very short notice. A great pleasure to work with!
Sr. Scientific Expert, Pharmaceutical Manufacturer for category-leading injectables, devices, and skincare products
Good communication and support, especially with the new challenges of MDR and MDCG documents.
Team Lead Clinical Product Management, Manufacturer of Sustainable Solutions for Ophthalmology
The flexibility, speed, and communication of the PRO-LIANCE staff were great! I found the constructive discussions particularly valuable.
Medical Affairs Manager, manufacturer of medical devices with a focus on inhalation devices